Cargando…
Cyclopentenylcytosine (CPE-C): In Vitro and In Vivo Evaluation as an Antiviral against Adenoviral Ocular Infections
Adenoviruses are the major cause of ocular viral infections worldwide. Currently, there is no approved antiviral treatment for these eye infections. Cyclopentenylcytosine (CPE-C) is an antiviral that has demonstrated activity against more than 20 viruses. The goals of the current study were to deter...
Autores principales: | Romanowski, Eric G., Yates, Kathleen A., Gordon, Y. Jerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343472/ https://www.ncbi.nlm.nih.gov/pubmed/37446740 http://dx.doi.org/10.3390/molecules28135078 |
Ejemplares similares
-
Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase
por: de Clercq, Erik, et al.
Publicado: (1991) -
Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular Model
por: Romanowski, Eric G., et al.
Publicado: (2021) -
The in vitro Evaluation of the Activity of COVID-19 Antiviral Drugs Against Adenovirus
por: Romanowski, Eric G, et al.
Publicado: (2021) -
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication Model
por: Romanowski, Eric G., et al.
Publicado: (2022) -
Clostridium Perfringens Enterotoxin (CPE) and CPE-Binding Domain (c-CPE) for the Detection and Treatment of Gynecologic Cancers
por: Black, Jonathan D., et al.
Publicado: (2015)